Pediatric Aggressive Mature B-Cell Lymphomas, Version 3.2022

Matthew Barth; Ana C. Xavier; Saro Armenian; Anthony N. Audino; Lindsay Blazin; David Bloom; Jong Chung; Kimberly Davies; Hilda Ding; James B. Ford; Paul J. Galardy; Rabi Hanna; Robert Hayashi; Cathy Lee-Miller; Andrea Judit Machnitz; Kelly W. Maloney; Lianna Marks; Paul L. Martin; David McCall; Martha Pacheco; Anne F. Reilly; Mikhail Roshal; Sophie Song; Joanna Weinstein; Sara Zarnegar-Lumley; Nicole McMillian; Ryan Schonfeld; Hema Sundar

doi:10.6004/jnccn.2022.0057

Pediatric Aggressive Mature B-Cell Lymphomas, Version 3.2022

Matthew Barth, Ana C. Xavier, Saro Armenian, Anthony N. Audino, Lindsay Blazin, David Bloom, Jong Chung, Kimberly Davies, Hilda Ding, James B. Ford, Paul J. Galardy, Rabi Hanna, Robert Hayashi, Cathy Lee-Miller, Andrea Judit Machnitz, Kelly W. Maloney, Lianna Marks, Paul L. Martin, David McCall, Martha PachecoAnne F. Reilly, Mikhail Roshal, Sophie Song, Joanna Weinstein, Sara Zarnegar-Lumley, Nicole McMillian, Ryan Schonfeld, Hema Sundar

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Abstract

NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Pediatric Aggressive Mature B-Cell Lymphomas include recommendations for the diagnosis and management of pediatric patients with primary mediastinal large B-cell lymphoma (PMBL) and sporadic variants of Burkitt lymphoma and diffuse large B-cell lymphoma. PMBL is now considered as a distinct entity arising from mature thymic B-cells accounting for 2% of mature B-cell lymphomas in children and adolescents. This discussion section includes the recommendations outlined in the NCCN Guidelines for the diagnosis and management of pediatric patients with PMBL.

Original language	English
Pages (from-to)	1267-1275
Number of pages	9
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	20
Issue number	11
DOIs	https://doi.org/10.6004/jnccn.2022.0057
State	Published - Nov 2022

Access to Document

10.6004/jnccn.2022.0057

Cite this

Barth, M., Xavier, A. C., Armenian, S., Audino, A. N., Blazin, L., Bloom, D., Chung, J., Davies, K., Ding, H., Ford, J. B., Galardy, P. J., Hanna, R., Hayashi, R., Lee-Miller, C., Machnitz, A. J., Maloney, K. W., Marks, L., Martin, P. L., McCall, D., ... Sundar, H. (2022). Pediatric Aggressive Mature B-Cell Lymphomas, Version 3.2022. JNCCN Journal of the National Comprehensive Cancer Network, 20(11), 1267-1275. https://doi.org/10.6004/jnccn.2022.0057

@article{0d4c77db3c3b48349c5a8aa65a0800e2,

title = "Pediatric Aggressive Mature B-Cell Lymphomas, Version 3.2022",

abstract = "NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Pediatric Aggressive Mature B-Cell Lymphomas include recommendations for the diagnosis and management of pediatric patients with primary mediastinal large B-cell lymphoma (PMBL) and sporadic variants of Burkitt lymphoma and diffuse large B-cell lymphoma. PMBL is now considered as a distinct entity arising from mature thymic B-cells accounting for 2% of mature B-cell lymphomas in children and adolescents. This discussion section includes the recommendations outlined in the NCCN Guidelines for the diagnosis and management of pediatric patients with PMBL.",

author = "Matthew Barth and Xavier, {Ana C.} and Saro Armenian and Audino, {Anthony N.} and Lindsay Blazin and David Bloom and Jong Chung and Kimberly Davies and Hilda Ding and Ford, {James B.} and Galardy, {Paul J.} and Rabi Hanna and Robert Hayashi and Cathy Lee-Miller and Machnitz, {Andrea Judit} and Maloney, {Kelly W.} and Lianna Marks and Martin, {Paul L.} and David McCall and Martha Pacheco and Reilly, {Anne F.} and Mikhail Roshal and Sophie Song and Joanna Weinstein and Sara Zarnegar-Lumley and Nicole McMillian and Ryan Schonfeld and Hema Sundar",

year = "2022",

month = nov,

doi = "10.6004/jnccn.2022.0057",

language = "English",

volume = "20",

pages = "1267--1275",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

number = "11",

}

Barth, M, Xavier, AC, Armenian, S, Audino, AN, Blazin, L, Bloom, D, Chung, J, Davies, K, Ding, H, Ford, JB, Galardy, PJ, Hanna, R, Hayashi, R, Lee-Miller, C, Machnitz, AJ, Maloney, KW, Marks, L, Martin, PL, McCall, D, Pacheco, M, Reilly, AF, Roshal, M, Song, S, Weinstein, J, Zarnegar-Lumley, S, McMillian, N, Schonfeld, R & Sundar, H 2022, 'Pediatric Aggressive Mature B-Cell Lymphomas, Version 3.2022', JNCCN Journal of the National Comprehensive Cancer Network, vol. 20, no. 11, pp. 1267-1275. https://doi.org/10.6004/jnccn.2022.0057

TY - JOUR

T1 - Pediatric Aggressive Mature B-Cell Lymphomas, Version 3.2022

AU - Barth, Matthew

AU - Xavier, Ana C.

AU - Armenian, Saro

AU - Audino, Anthony N.

AU - Blazin, Lindsay

AU - Bloom, David

AU - Chung, Jong

AU - Davies, Kimberly

AU - Ding, Hilda

AU - Ford, James B.

AU - Galardy, Paul J.

AU - Hanna, Rabi

AU - Hayashi, Robert

AU - Lee-Miller, Cathy

AU - Machnitz, Andrea Judit

AU - Maloney, Kelly W.

AU - Marks, Lianna

AU - Martin, Paul L.

AU - McCall, David

AU - Pacheco, Martha

AU - Reilly, Anne F.

AU - Roshal, Mikhail

AU - Song, Sophie

AU - Weinstein, Joanna

AU - Zarnegar-Lumley, Sara

AU - McMillian, Nicole

AU - Schonfeld, Ryan

AU - Sundar, Hema

PY - 2022/11

Y1 - 2022/11

N2 - NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Pediatric Aggressive Mature B-Cell Lymphomas include recommendations for the diagnosis and management of pediatric patients with primary mediastinal large B-cell lymphoma (PMBL) and sporadic variants of Burkitt lymphoma and diffuse large B-cell lymphoma. PMBL is now considered as a distinct entity arising from mature thymic B-cells accounting for 2% of mature B-cell lymphomas in children and adolescents. This discussion section includes the recommendations outlined in the NCCN Guidelines for the diagnosis and management of pediatric patients with PMBL.

AB - NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Pediatric Aggressive Mature B-Cell Lymphomas include recommendations for the diagnosis and management of pediatric patients with primary mediastinal large B-cell lymphoma (PMBL) and sporadic variants of Burkitt lymphoma and diffuse large B-cell lymphoma. PMBL is now considered as a distinct entity arising from mature thymic B-cells accounting for 2% of mature B-cell lymphomas in children and adolescents. This discussion section includes the recommendations outlined in the NCCN Guidelines for the diagnosis and management of pediatric patients with PMBL.

UR - http://www.scopus.com/inward/record.url?scp=85141497393&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2022.0057

DO - 10.6004/jnccn.2022.0057

M3 - Article

C2 - 36351334

AN - SCOPUS:85141497393

SN - 1540-1405

VL - 20

SP - 1267

EP - 1275

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 11

ER -

Pediatric Aggressive Mature B-Cell Lymphomas, Version 3.2022

Abstract

Access to Document

Other files and links

Fingerprint

Cite this